Track topics on Twitter Track topics that are important to you
NEW YORK CITY (dpa-AFX) - Atomwise Inc. announced an evaluation agreement with Pfizer Inc. (PFE). Pfizer will evaluate Atomwise's platform to identify potential drug candidates for up to three tar...
The partnership with the Massachusetts-based CRO coul
Charles River and Atomwise have formed a strategic alliance aimed at accelerating the drug discovery process using AI-powered design technology.
Charles River and Atomwise have formed a strategic alliance aimed at accelerating the drug discovery process using AI-powered drug design technology.
Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer. In the agreement, Pfizer will pay a technology access The post Pfi...
Charles River said it is reaffirming the commitment to the future of drug discovery by advancing its integrated, innovative early-stage platform. As part of the deal, the partnership The post Charles...
Atomwise Inc., a leader in Artificial Intelligence (AI) for drug discovery and design, has entered into an evaluation agreement with Pfizer Inc. (NYSE: PFE). Pfizer will evaluate ...
Charles River’s clients gain access to Atomwise’s Artificial Intelligence (AI) technology to improve novelty, quality and efficiency of preclinical drug discovery. ...
Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful...
We have published hundreds of Atomwise, Inc. news stories on BioPortfolio along with dozens of Atomwise, Inc. Clinical Trials and PubMed Articles about Atomwise, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atomwise, Inc. Companies in our database. You can also find out about relevant Atomwise, Inc. Drugs and Medications on this site too.